## Abstract Parathyroid hormone (PTH) regulates bone remodeling and calcium homeostasis by acting on osteoblasts. Recently, the gene expression profile changes in the rat PTH (1–34, 10^−8^M)‐treated rat osteoblastic osteosarcoma cell line, UMR 106‐01, using DNA microarray analysis showed that mRNA
In vivo demonstration that parathyroid hormone and parathyroid hormone–related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor
✍ Scribed by Jennifer H. Pollock; Michelle J. Blaha; Sandra A. Lavish; Sharon Stevenson; Edward M. Greenfield
- Publisher
- American Society for Bone and Mineral Research
- Year
- 2009
- Tongue
- English
- Weight
- 963 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0884-0431
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have previously reported that parathyroid hormone (PTH) and PTH related protein (PTHrP) stimulate expression of interleukin‐6 (IL‐6) and leukemia inhibitory factor (LIF) in osteoblasts in vitro. In the current study, we have developed a model of hormone injection into the subcutaneous space overlying mouse parietal bones to demonstrate that similar processes occur in osteoblasts in vivo. Specifically, PTH and PTHrP rapidly and transiently induce expression of the mRNAs encoding IL‐6 and LIF. The effects are dose‐dependent, with a maximal stimulation of approximately 50‐fold for each cytokine. Although PTH and PTHrP activate both adenyl cyclase and phospholipase C‐dependent signal transduction pathways, stimulation of IL‐6 and LIF depends on adenyl cyclase since it is not reproduced by PTH(3–34), a partial agonist that only activates phospholipase C. These results confirm our previous in vitro studies and support the hypothesis that IL‐6 and/or LIF are physiologically important mediators of at least some of the actions of PTH and PTHrP.
📜 SIMILAR VOLUMES
## Abstract Parathyroid hormone (PTH), an anabolic agent for bone metabolism, has profound effects on gene expression in the osteoblast. Recently, we identified that amphiregulin (AR), an EGF‐like ligand, is an immediate early gene for PTH treatment and has an important role in bone metabolism. In